BSX - Boston Scientific Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
60.23B
Enterprise Value 3
71.15B
Trailing P/E
56.12
Forward P/E 1
24.28
PEG Ratio (5 yr expected) 1
2.48
Price/Sales (ttm)
5.80
Price/Book (mrq)
6.21
Enterprise Value/Revenue 3
6.85
Enterprise Value/EBITDA 6
25.93

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 318.24%
S&P500 52-Week Change 325.78%
52 Week High 346.62
52 Week Low 334.35
50-Day Moving Average 344.64
200-Day Moving Average 342.35

Share Statistics

Avg Vol (3 month) 36.42M
Avg Vol (10 day) 38.84M
Shares Outstanding 51.39B
Float 1.39B
% Held by Insiders 10.23%
% Held by Institutions 195.27%
Shares Short (Dec 30, 2019) 414.05M
Short Ratio (Dec 30, 2019) 42.4
Short % of Float (Dec 30, 2019) 41.14%
Short % of Shares Outstanding (Dec 30, 2019) 41.01%
Shares Short (prior month Nov 28, 2019) 412.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Nov 05, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 10.49%
Operating Margin (ttm)17.14%

Management Effectiveness

Return on Assets (ttm)4.72%
Return on Equity (ttm)12.12%

Income Statement

Revenue (ttm)10.39B
Revenue Per Share (ttm)7.48
Quarterly Revenue Growth (yoy)13.10%
Gross Profit (ttm)6.99B
EBITDA 2.74B
Net Income Avi to Common (ttm)1.09B
Diluted EPS (ttm)0.77
Quarterly Earnings Growth (yoy)-70.80%

Balance Sheet

Total Cash (mrq)277M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)11.2B
Total Debt/Equity (mrq)115.48
Current Ratio (mrq)1.14
Book Value Per Share (mrq)6.96

Cash Flow Statement

Operating Cash Flow (ttm)1.16B
Levered Free Cash Flow (ttm)476.38M